Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isovue-250 vs Visipaque 270 in Peripheral DSA
NCT00740207Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Sep 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of iopamidol in peripheral arterial occlusive disease (PAOD), sponsored by Bracco Diagnostics Inc.. Started Sep 2008; status: completed.
02
Drugs
iopamidol
03
Conditions
peripheral arterial occlusive disease (PAOD)
Beyond the preview
Go deeper on NCT00740207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740207.